OV101 regimen 2

( DrugBank: - / KEGG DRUG: - )

1 disease

ID	Disease name (Link within this page)	Number of trials
201	Angelman syndrome	1

201. Angelman syndrome

Clinical trials : 25 / Drugs : 40 - (DrugBank : 11) / Drug target genes : 22 - Drug target pathways : 20

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02996305 (ClinicalTrials.gov)	January 2016	2/12/2016	A Study in Adults and Adolescents With Angelman Syndrome	A Phase 2 Adult and Adolescent Angelman Syndrome Clinical Trial: A Randomized, Double-Blind, Safety ...	Angelman Syndrome	Drug: OV101 Regimen 1;Drug: OV101 regimen 2;Other: Placebo	Ovid Therapeutics Inc.	NULL	Completed	13 Years	49 Years	All	88	Phase 2	United States;Israel

First Previous1Next Last